Related Experiment Video
Updated: Jun 24, 2026

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency
Published on: June 10, 2018
Genetic control of wayward pluripotent stem cells and their progeny after transplantation
Maija Kiuru1, Julie L Boyer, Timothy P O'Connor
1Department of Genetic Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Abstract:
The proliferative capacity of pluripotent stem cells and their progeny brings a unique aspect to therapeutics, in that once a transplant is initiated the therapist no longer has control of the therapy. In the context of the recent FDA approval of a human ESC trial and report of a neuronal-stem-cell-derived tumor in a human trial, strategies need to be developed to control wayward pluripotent stem cells. Here, we focus on one approach: direct genetic modification of the cells prior to transplantation with genes that can prevent the adverse events and/or eliminate the transplanted cells and their progeny.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic cells are...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic to iPS Cell Reprogramming
Stem Cell Culture
Methods of Nuclear Reprogramming
